SKLOi001-A

A P E C

The cell line is not submitted yet.

(only basic data is shown)

iPSC Line
hPSCreg name	SKLOi001-A
Cite as:	SKLOi001-A (RRID:CVCL_YT42)
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	30th March 2020
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	State Key Laboratory of Ophthalmology (SKLO)
External iPSC Databases
Cellosaurus	CVCL_YT42
Wikidata	Q98132681
General iPSC Information
Publications	Chen Z et al. Generation of an iPSC line (SKLOi001-A) from a patient with CLCN2-related leukoencephalopathy. Stem cell research. 2020 May;45:101769. Pushp P et al. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine. Stem cell reviews and reports. 2021 Jun;17(3):748-776. Wang Z et al. Current status and future prospects of patient-derived induced pluripotent stem cells. Human cell. 2021 Nov;34(6):1601-1616. Xu Ping et al. Biallelic CLCN2 mutations cause retinal degeneration by impairing retinal pigment epithelium phagocytosis and chloride channel function. Human Genetics. 2023-04-00. Yang Lu et al. Targeting astrocytic CLC2(CLCN2) restores myelin regeneration through inhibition of SPP1/CD44 signaling pathway in leukoencephalopathy. Molecular Psychiatry. 2026-01-00.